- Home
- PRG vs RCKT Comparison
PRG vs RCKT Comparison
Compare PRG & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRG
- RCKT
- Stock Information
- Founded
- PRG 2020
- RCKT 1999
- Country
- PRG United States
- RCKT United States
- Employees
- PRG N/A
- RCKT N/A
- Industry
- PRG Diversified Commercial Services
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- PRG Consumer Discretionary
- RCKT Health Care
- Exchange
- PRG Nasdaq
- RCKT Nasdaq
- Market Cap
- PRG 1.4B
- RCKT 328.6M
- IPO Year
- PRG N/A
- RCKT N/A
- Fundamental
- Price
- PRG $35.39
- RCKT $3.03
- Analyst Decision
- PRG Hold
- RCKT Buy
- Analyst Count
- PRG 5
- RCKT 13
- Target Price
- PRG $37.20
- RCKT $12.96
- AVG Volume (30 Days)
- PRG 309.9K
- RCKT 5.7M
- Earning Date
- PRG 10-22-2025
- RCKT 11-06-2025
- Dividend Yield
- PRG 1.46%
- RCKT N/A
- EPS Growth
- PRG 109.72
- RCKT N/A
- EPS
- PRG 5.11
- RCKT N/A
- Revenue
- PRG $2,518,216,000.00
- RCKT N/A
- Revenue This Year
- PRG $1.44
- RCKT N/A
- Revenue Next Year
- PRG $3.56
- RCKT $108.43
- P/E Ratio
- PRG $6.96
- RCKT N/A
- Revenue Growth
- PRG 5.17
- RCKT N/A
- 52 Week Low
- PRG $23.50
- RCKT $2.19
- 52 Week High
- PRG $50.28
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- PRG 58.23
- RCKT 42.39
- Support Level
- PRG $35.25
- RCKT $3.09
- Resistance Level
- PRG $36.33
- RCKT $3.29
- Average True Range (ATR)
- PRG 0.82
- RCKT 0.17
- MACD
- PRG -0.11
- RCKT -0.03
- Stochastic Oscillator
- PRG 41.94
- RCKT 0.00
About PRG PROG Holdings Inc.
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.